Skip to main content

Published locations for Topical histone deacetylase inhibitor reduced BCC size in phase 2 study

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Topical histone deacetylase inhibitor reduced BCC size in phase 2 study

User login

  • Reset your password
  • /content/topical-histone-deacetylase-inhibitor-reduced-bcc-size-phase-2-study
  • /edermatologynews/article/241491/nonmelanoma-skin-cancer/topical-histone-deacetylase-inhibitor
  • /oncologypractice/article/241491/nonmelanoma-skin-cancer/topical-histone-deacetylase-inhibitor
  • /hematology-oncology/article/241491/nonmelanoma-skin-cancer/topical-histone-deacetylase-inhibitor
  • /dermatology/article/241491/nonmelanoma-skin-cancer/topical-histone-deacetylase-inhibitor-reduced-bcc